<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>6979</number>
    <updateDate>2024-06-11T15:45:39Z</updateDate>
    <updateDateIncludingText>2024-06-11T15:45:39Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2024-01-11</introducedDate>
    <congress>118</congress>
    <constitutionalAuthorityStatementText><![CDATA[<pre>[Congressional Record Volume 170, Number 6 (Thursday, January 11, 2024)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. NEGUSE:H.R. 6979.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8The single subject of this legislation is:To amend the Internal Revenue Code of 1986 to provide acredit to small businesses for research activities related tothe mitigation of certain drug threats.[Page H108]</pre>]]></constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hswm00</systemCode>
        <name>Ways and Means Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2024-01-11T15:03:00Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2024-01-11</actionDate>
        <text>Referred to the House Committee on Ways and Means.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hswm00</systemCode>
            <name>Ways and Means Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-01-11</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-01-11</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>N000191</bioguideId>
        <fullName>Rep. Neguse, Joe [D-CO-2]</fullName>
        <firstName>Joe</firstName>
        <lastName>Neguse</lastName>
        <party>D</party>
        <state>CO</state>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000631</bioguideId>
        <fullName>Rep. Dean, Madeleine [D-PA-4]</fullName>
        <firstName>Madeleine</firstName>
        <lastName>Dean</lastName>
        <party>D</party>
        <state>PA</state>
        <district>4</district>
        <sponsorshipDate>2024-01-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>B001298</bioguideId>
        <fullName>Rep. Bacon, Don [R-NE-2]</fullName>
        <firstName>Don</firstName>
        <lastName>Bacon</lastName>
        <party>R</party>
        <state>NE</state>
        <district>2</district>
        <sponsorshipDate>2024-01-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>T000483</bioguideId>
        <fullName>Rep. Trone, David J. [D-MD-6]</fullName>
        <firstName>David</firstName>
        <lastName>Trone</lastName>
        <party>D</party>
        <state>MD</state>
        <middleName>J.</middleName>
        <district>6</district>
        <sponsorshipDate>2024-01-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000599</bioguideId>
        <fullName>Rep. Lawler, Michael [R-NY-17]</fullName>
        <firstName>Michael</firstName>
        <lastName>Lawler</lastName>
        <party>R</party>
        <state>NY</state>
        <district>17</district>
        <sponsorshipDate>2024-01-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001133</bioguideId>
        <fullName>Rep. Ciscomani, Juan [R-AZ-6]</fullName>
        <firstName>Juan</firstName>
        <lastName>Ciscomani</lastName>
        <party>R</party>
        <state>AZ</state>
        <district>6</district>
        <sponsorshipDate>2024-01-11</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M001221</bioguideId>
        <fullName>Rep. Molinaro, Marcus J. [R-NY-19]</fullName>
        <firstName>Marcus</firstName>
        <lastName>Molinaro</lastName>
        <party>R</party>
        <state>NY</state>
        <middleName>J.</middleName>
        <district>19</district>
        <sponsorshipDate>2024-04-05</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Taxation</name>
    </policyArea>
    <subjects>
      <legislativeSubjects/>
      <policyArea>
        <name>Taxation</name>
        <updateDate>2024-02-13T19:15:31Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2024-01-11</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-02-14T20:04:17Z</updateDate>
        <text><![CDATA[ <p>This bill allows certain small businesses a new tax credit for 10% of their qualified drug threat mitigation research expenses. Such expenses include research into mitigating or treating the effects of specified drugs, including any emerging drugs, fentanyl, a fentanyl-related substance, or methamphetamine.</p>]]></text>
      </summary>
    </summaries>
    <title>To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.</title>
        <updateDate>2024-06-11T15:45:39Z</updateDate>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the Internal Revenue Code of 1986 to provide a credit to small businesses for research activities related to the mitigation of certain drug threats.</title>
        <updateDate>2024-03-18T22:06:21Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2024-01-11T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr6979ih/xml/BILLS-118hr6979ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2024-01-11</actionDate>
      <text>Referred to the House Committee on Ways and Means.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
